A Novo executive noted that many customers are unaware that the company already makes oral semaglutide for type 2 diabetes ...

Three major reviews commissioned by the World Health Organization find that GLP-1 drugs including tirzepatide (sold as Mounjaro and Zepbound), semaglutide (Ozempic and Wegovy), and liraglutide ...

Time for Ozempic to walk the plank? Top dietitians in Australia this week are waving a red flag about an unforeseen impact of ...

Novo Nordisk's plan to gain ground in the GLP-1 space is slowly taking shape.

Weight loss drugs can be life changing but are not without risks,' says Dr Vishnu Radhakrishnan as he explains the truth ...

Ozempic and similar weight loss drugs offer major benefits for obesity and heart health, but side effects, muscle loss, and ...

Treating kidney disease GLP-1s show higher risk than SGLT2 inhibitors in kidney outcomes, but lower albuminuria and mortality rates.

The study found that the perceived effectiveness of Ozempic for weight loss is the primary driver of patient satisfaction and intent to continue treatment, even when experiencing side effects.

A study analysing online reviews found that many people keep taking Ozempic for weight loss if they feel it is working, even when side effects continue. Instead, people were more likely to discontinue ...